Letter: dry blood spots for anti-TNF treatment monitoring in IBD

被引：6

作者：

Vande Casteele, N. ^{[1
]}

Brecx, S. ^{[1
]}

Declerck, P. ^{[1
]}

Ferrante, M. ^{[2
]}

Rutgeerts, P. ^{[2
]}

Vermeire, S. ^{[2
]}

Gils, A. ^{[1
]}

机构：

[1] Katholieke Univ Leuven, Lab Therapeut & Diagnost Antibodies, Louvain, Belgium

[2] UZ Leuven, Dept Gastroenterol, Louvain, Belgium

来源：

关键词：

ASSAYS;

D O I：

10.1111/apt.12283

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1024 / 1025

页数：2

共 5 条

[1] Ballet V, 2012, J CROHNS COLITIS, V6, pS6, DOI DOI 10.1016/S1873-9946(12)60012-9
[2] Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays
Casteele, N. Vande
Buurman, D. J.
Sturkenboom, M. G. G.
Kleibeuker, J. H.
Vermeire, S.
Rispens, T.
van der Kleij, D.
Gils, A.
Dijkstra, G.
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (08) : 765 - 771
[3] Systematic review: antibodies and anti-TNF-α levels in inflammatory bowel disease
Chaparro, M.
Guerra, I.
Munoz-Linares, P.
Gisbert, J. P.
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (09) : 971 - 986
[4] Dried Blood Spot Methods in Therapeutic Drug Monitoring: Methods, Assays, and Pitfalls
Edelbroek, Peter M.
van der Heijden, Jacques
Stolk, Leo M. L.
[J]. THERAPEUTIC DRUG MONITORING, 2009, 31 (03) : 327 - 336
[5] Timmerman P, 2011, BIOANALYSIS, V3, P1567, DOI [10.4155/bio.11.132, 10.4155/BIO.11.132]